A quantitative assay for immune status monitoring with an accurate correlation of neutralizing IgG antibodies
The LIAISON® SARS-CoV-2 TrimericS IgG assay is the second generation of DiaSorin serological tests with an important diagnostics improvement. The selection of a new recombinant Trimeric Spike glycoprotein as a capture antigen, offers a new product with high standard quality that provides the following benefits: